“Hot” tumors include diseases with proinflammatory TMEs and tumor‐infiltrating lymphocytes (TILs), which tend to have higher regulatory markers, including PD‐L1, IDO, Tregs, and ultimately promote tumor immune evasion.33 This evidence concerns the gene IDO1 and neoplasm.